The outbreak of SARS nosocomial infection in Taipei City Hospital Heping branch was already in 2003. It took nearly 5 months from the discovery of SARS to the final determination of which pathogen was infected. At the present time now, viruses are getting smarter and smarter. Fortunately, the virus is evolving, and medical technology is also advancing at the same time. In particular, the ability to quickly identify new viruses was completely unimaginable in the past.
Take the new coronavirus as an example. The new coronavirus is still raging around the world, and new virus strains have been discovered in various places one after another ,arousing great attention from all over the world. After the Chinese government official announced its pathogen on January 9, 2020, within a week, it confirmed the full genetic sequence of the new coronavirus based on Next Generation Sequencing (NGS). This shows that NGS genetic testing can accelerate the identification of unknown pathogenic microorganisms.
The culture time of the traditional pathogenic microorganism detection method is as long as 6-8 weeks, and the sensitivity is not high. It is unable to quickly identify the type of pathogen and provide physicians with antibiotics and multi-drug resistance (MDRO) and other relevant information. The risk of nosocomial infection delays the patient’s recovery and discharge time.
LEOPARD Gene provides metagenomic next-generation genetic sequencing (NGS) genetic testing services. Next-generation gene sequencing (NGS) is a high-throughput new technology that can sequence a large amount of DNA at the same time. It can be applied to the detection of unknown infectious pathogens, the identification and analysis of novel microorganisms, the whole sequencing of microbial genomes, the typing of microorganisms, the investigation of infectious disease clusters, the analysis and comparison of drug resistance genes, and the tracking of changes in microbial flora and so on, to assist physicians of emergency room and intensive care quickly detect unknown pathogenic microorganisms.